125 related articles for article (PubMed ID: 9268986)
1. Distinct effects of various p53 mutants on differentiation and viability of human K562 leukemia cells.
Kremenetskaya OS; Logacheva NP; Baryshnikov AY; Chumakov PM; Kopnin BP
Oncol Res; 1997; 9(4):155-66. PubMed ID: 9268986
[TBL] [Abstract][Full Text] [Related]
2. [The effect of the tumor suppressor p53 and its mutant forms on the differentiation and viability of K562 leukemic cells].
Kremenetskaia OS; Logacheva NP; Baryshnikov AIu; Chumakov PM; Kopnin BP
Tsitologiia; 1996; 38(12):1280-93. PubMed ID: 9163103
[TBL] [Abstract][Full Text] [Related]
3. Changes in p53 expression can modify cell shape of ras-transformed fibroblasts and epitheliocytes.
Gloushankova N; Ossovskaya V; Vasiliev J; Chumakov P; Kopnin B
Oncogene; 1997 Dec; 15(24):2985-9. PubMed ID: 9416842
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the tumor suppressor gene p53 in tumor necrosis factor-induced differentiation of the leukemic cell line K562.
Ehinger M; Nilsson E; Persson AM; Olsson I; Gullberg U
Cell Growth Differ; 1995 Jan; 6(1):9-17. PubMed ID: 7718488
[TBL] [Abstract][Full Text] [Related]
5. Stable reintroduction of wild-type P53 (MTmp53ts) causes the induction of apoptosis and neuroendocrine-like differentiation in human ductal pancreatic carcinoma cells.
Lang D; Miknyoczki SJ; Huang L; Ruggeri BA
Oncogene; 1998 Mar; 16(12):1593-602. PubMed ID: 9569027
[TBL] [Abstract][Full Text] [Related]
6. p53 re-expression inhibits proliferation and restores differentiation of human thyroid anaplastic carcinoma cells.
Moretti F; Farsetti A; Soddu S; Misiti S; Crescenzi M; Filetti S; Andreoli M; Sacchi A; Pontecorvi A
Oncogene; 1997 Feb; 14(6):729-40. PubMed ID: 9038381
[TBL] [Abstract][Full Text] [Related]
7. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
[TBL] [Abstract][Full Text] [Related]
8. Reconstitution of wild-type p53 expression triggers apoptosis in a p53-negative v-myc retrovirus-induced T-cell lymphoma line.
Wang Y; Ramqvist T; Szekely L; Axelson H; Klein G; Wiman KG
Cell Growth Differ; 1993 Jun; 4(6):467-73. PubMed ID: 8373731
[TBL] [Abstract][Full Text] [Related]
9. Co-transfection of p16(INK4a) and p53 genes into the K562 cell line inhibits cell proliferation.
Rui HB; Su JZ
Haematologica; 2002 Feb; 87(2):136-42. PubMed ID: 11836163
[TBL] [Abstract][Full Text] [Related]
10. Phorbol esters attenuate the expression of p53 in cells treated with doxorubicin and protect TS-P53/K562 from apoptosis.
Magnelli L; Cinelli M; Chiarugi V
Biochem Biophys Res Commun; 1995 Oct; 215(2):641-5. PubMed ID: 7488003
[TBL] [Abstract][Full Text] [Related]
11. p53-mediated differentiation of the erythroleukemia cell line K562.
Chylicki K; Ehinger M; Svedberg H; Bergh G; Olsson I; Gullberg U
Cell Growth Differ; 2000 Jun; 11(6):315-24. PubMed ID: 10910098
[TBL] [Abstract][Full Text] [Related]
12. [New insight into the mechanism of p53 inducing leukemia cell apoptosis].
Chen YZ; Wu Y; Liang M; Li NN; Zhang ZX; Lu LH
Zhonghua Xue Ye Xue Za Zhi; 2003 Dec; 24(12):640-3. PubMed ID: 14761612
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 expression in F-MuLV-induced erythroleukemias: a role for the anti-apoptotic action of Bcl-2 during tumor progression.
Howard JC; Li Q; Chu W; Zochodne B; Kapoor M; Ung Y; Rosen K; Ben-David Y
Oncogene; 2001 Apr; 20(18):2291-300. PubMed ID: 11402324
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of c-Myc on p53-induced apoptosis in leukemia cells. Microarray analysis reveals defective induction of p53 target genes and upregulation of chaperone genes.
Ceballos E; Muñoz-Alonso MJ; Berwanger B; Acosta JC; Hernández R; Krause M; Hartmann O; Eilers M; León J
Oncogene; 2005 Jun; 24(28):4559-71. PubMed ID: 15856024
[TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein.
Wesierska-Gadek J; Schmid G
Cell Mol Biol Lett; 2001; 6(2):117-40. PubMed ID: 11544635
[TBL] [Abstract][Full Text] [Related]
16. Cell-type- and promoter-dependent ts phenotype of p53 Val135.
Sehgal PB; Margulies L
Oncogene; 1993 Dec; 8(12):3417-9. PubMed ID: 8247545
[TBL] [Abstract][Full Text] [Related]
17. [Induction of hyperdiploidy and chromosome breaks in LIM1215 cells expressing the exogenous mutant p53].
Agapova LS; Turovets NA; Ivanov AV; Il'inskaia GV; Chumakov PM
Genetika; 1996 Aug; 32(8):1080-7. PubMed ID: 8964480
[TBL] [Abstract][Full Text] [Related]
18. The tumor suppressor gene p53 can mediate transforming growth [corrected] factor beta1-induced differentiation of leukemic cells independently of activation of the retinoblastoma protein.
Ehinger M; Bergh G; Johnsson E; Gullberg U; Olsson I
Cell Growth Differ; 1997 Oct; 8(10):1127-37. PubMed ID: 9342191
[TBL] [Abstract][Full Text] [Related]
19. p51A (TAp63gamma), a p53 homolog, accumulates in response to DNA damage for cell regulation.
Katoh I; Aisaki KI; Kurata SI; Ikawa S; Ikawa Y
Oncogene; 2000 Jun; 19(27):3126-30. PubMed ID: 10871867
[TBL] [Abstract][Full Text] [Related]
20. c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells.
Ceballos E; Delgado MD; Gutierrez P; Richard C; Müller D; Eilers M; Ehinger M; Gullberg U; León J
Oncogene; 2000 Apr; 19(18):2194-204. PubMed ID: 10822369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]